Short Report
|
3
|
Resverlogix Corp.
|
Feb 15, 2019 04:23PM
|
Short squeeze could be very ineffective
|
6
|
Resverlogix Corp.
|
Jun 05, 2018 09:11PM
|
Shorts
|
3
|
Resverlogix Corp.
|
Apr 26, 2021 02:40PM
|
Since we're speculating
|
6
|
Resverlogix Corp.
|
Jan 05, 2018 05:21PM
|
Story time with tada
|
5
|
Resverlogix Corp.
|
Feb 15, 2018 05:55PM
|
Thank you for your civility
|
6
|
Resverlogix Corp.
|
Dec 01, 2019 12:01AM
|
Thank you to those who voted
|
5
|
Resverlogix Corp.
|
Apr 11, 2017 03:56PM
|
The beginning of the end game
|
6
|
Resverlogix Corp.
|
Jul 31, 2018 06:23PM
|
The CKD opportunity
|
10
|
Resverlogix Corp.
|
Jul 27, 2017 12:02AM
|
The jaded group of posters
|
9
|
Resverlogix Corp.
|
Nov 01, 2021 12:49PM
|
The journey to the finish line
|
3
|
Resverlogix Corp.
|
May 12, 2018 11:33AM
|
The last couple of minutes of Tax Loss Selling
|
10
|
Resverlogix Corp.
|
Dec 27, 2019 03:53PM
|
The leveraged play
|
2
|
Resverlogix Corp.
|
Jun 10, 2019 04:13PM
|
The offering
|
3
|
Resverlogix Corp.
|
May 23, 2019 12:54PM
|
The Real Value of a Break Through Therapy Designation
|
3
|
Resverlogix Corp.
|
Jul 11, 2020 07:03PM
|
The Shorts
|
4
|
Resverlogix Corp.
|
Sep 07, 2018 02:46PM
|
There is hope for us
|
8
|
Zenith Epigenetics
|
Jan 08, 2018 05:10PM
|
To a great 2017
|
4
|
Resverlogix Corp.
|
Jan 01, 2017 03:00AM
|
Today's wrap...my view
|
6
|
Resverlogix Corp.
|
Jun 12, 2019 06:07PM
|
Two big thank you’s
|
|
Zenith Epigenetics
|
Nov 24, 2022 01:46PM
|